Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: A single institution experience

Hematology

Volumn 8, Issue 3, 2003, Pages 151-154

  Ruiz Argüelles, Guillermo J ^a,b   López Martínez, Briceida ^b   Gómez Rangel, David ^a   Estrada, Erick ^a   Marín López, Antonio ^c   Bravo Hernández, Gerardo ^a,c   Hernández, Juan Manuel ^c  

^a Ctro Hematol Med Int de Puebla   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c Serv Integ de Med Trans Puebla   (Mexico)

Author keywords

Bone marrow; Requirements; Transfusions; Transplants

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BLOOD DERIVATIVE; BUSULFAN; CD34 ANTIGEN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUDARABINE; ITRACONAZOLE; METHOTREXATE; ONDANSETRON;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOGRAFT; APHERESIS; ARTICLE; BLACKFAN DIAMOND ANEMIA; BLOOD TRANSFUSION; CANCER PATIENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CORRELATION ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; ERYTHROCYTE TRANSFUSION; EXPERIENCE; EXPOSURE; GRAFT REJECTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HUMAN; LUNG CARCINOMA; NONHODGKIN LYMPHOMA; OUTPATIENT CARE; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION;

EID: 0038798003     PISSN: 10245332     EISSN: None     Source Type: Journal    
DOI: 10.1080/1024533031000084196     Document Type: Article

References (20)

1. Thomas, E.D. (1995) "Hematopoietic stem cell transplantation", Sci. Am. 272, 38.
2. Ruiz-Argüelles, G.J., Ruiz-Argüelles, A., Alemán-Hoey, D.D., Arizpe-Bravo, D., Marín-López, A. and Ocejo-Rodríguez, A. (1993) "Autotrasplante en leucemia aguda de células totipotenciales movilizadas con filgrastim", Rev. Investig. Clín. Méx. 45, 479-480.
3. Ruiz-Argüelles, G.J., Ruiz-Argüelles, A., Pérez-Romano, B., Marín-López, A. and Delgado-Lamas, J.L. (1998) "Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis", Am. J. Hematol. 58, 161-164.
4. Ruiz-Argüelles, G.J., Lobato-Mendizábal, E., Ruiz-Argüelles, A., Pérez-Romano, B., Arizpe-Bravo, D. and Marín-López, A. (1999) "Non-cryopreserved unmanipulated hematopoietic peripheral blood stem cell autotransplant program: long term results", Arch. Med. Res. 30, 380-384.
5. Gómez-Almaguer, D., Ruiz-Argüelles, G.J., Ruiz-Argüelles, A., González-Llano, O., Cantú, O.E. and Hernández, N.E. (2000) "Hematopoietic stem cell allografts, using a nonmyeloablative conditioning regimen can be safely performed on an outpatient basis", Bone Marrow Transplant. 25, 131-133.
6. Ruiz-Argüelles, G.J., Gómez-Almaguer, D., Ruiz-Argüelles, A., González-Llano, O., Cantú, O.G. and Jaime Pérez, J.C. (2001) "Results of an outpatient-based stem cell allotransplant program using non-myeloablative conditioning regimens", Am. J. Hematol. 66, 241-244.
7. Ruiz-Argüelles, G.J. (2002) "Allogeneic stem cell transplantation using non-myeloablative conditioning regimens:results of the Mexican approach", Int. J. Hematol. 76(Suppl. 1), 376-379.
8. Kessinger, A., Armitage, J.O., Landmark, J.D., Smith, D.M. and Weisenburger, D.D. (1988) "Autologous peripheral hematopoietic stem cell transplantation restores hemopoietic function following marrow ablative therapy", Blood 71, 723-727.
9. Ruiz-Argüelles, A. (1992) "Flow cytometry in the clinical laboratory Principles, applications and problems", Ann. Biol. Clin. 50, 735-743.
10. Ruiz-Argüelles, A. and Orfao, A. (1996) "Caracterización y evaluación de células totipotenciales en sangre periférica y médula ósea", In: Ruiz-Argüelles, G.J. and San-Miguel, J.F., eds, Actualización en Leucemias (Editorial Médica Panamericana, México City), pp 79-82.
11. Ruiz-Argüelles, G.J., Sánchez-Medal, L., Loría, A., Piedras, J. and Córdova, M.S. (1980) "Red cell indices in normal adults residing at altitudes from sea level to 2670 meters", Am. J. Hematol. 8, 265-269.
12. Ruiz-Argüelles, G.J., Ruiz-Argüelles, A., Gómez-Almaguer, D., López-Martínez, B., Abreu-Díaz, G., Bravo, G. and Jaime-Pérez, J.C. (2001) "Features of the engraftment of allogeneic hematopoietic stem cells using reduced-intesity conditioning regimens", Leuk. Lymphoma 42, 145-150.
13. Chandy, M. (1999) "Management of hematological diseases in developing countries: socio-economic aspects", In: Schechter, G.P., Hoffman, R. and Schrier, S.L., eds, Hematology 1999 (The American Society of Hematology Education Program Book, Washington, U.S.A.), pp 73-76.
14. Ruiz-Argüelles, G.J. and Ruiz-Reyes, G. (1996) "El tratamiento de las leucemias en países en desarrollo", In: Ruiz-Argüelles, G.J. and San-Miguel, J.E, eds, Actualización en Leucemias (Editorial Médica Panamericana, México City, México), pp 147-151.
15. Patterson, K. (1992) "Blood and blood product transfusion during bone marrow transplantation", In: Treleaven, J. and Barret, J., eds, Blood and blood product transfusion during bone marrow transplantation (Churchill Livingstone, London), pp 307-313.
16. Smith, O.P., Prentice, H.G., Hazlehurst, G., Brozovic, B., Hoffbrand, A.V. and Mehta, A.B. (1991) "Blood product support in patients undergoing chemotherapy and autologous or allogeneic bone marrow transplantation for hematological malignancies", Clin. Lab. Haematol. 13, 107-114.
17. Ballen, K.K., Ford, P.A., Waitkus, H., Emmons, R.V., Levy, W., Doyle, P., Stewart, F.M., Quesenberry, P.J. and Becker, P.S. (2000) "Succesful autologous bone marrow transplant without the use of blood product support", Bone Marrow Transplant. 26, 227-229.
18. DiPersio, J.F., Khoury, H., Haug, J., Vij, R., Adkins, D.R., Goodnough, L.T. and Brown, R.A. (2000) "Innovations in allogeneic stem-cell transplantation", Semin Hematol. 37(Suppl. 1), 33-41.
19. Shaugnessy, P.J., Ornstein, D., Ririe, D., Callander, N., Anderson, J.E., Pollack, M.S., Freytes, C.O., Cruz, J., Rodríguez, T. and Bachier, C. (2002) "Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: The Texas transplant consortium experience", Biol Blood Marrow Transplant. 8, 420-428.
20. O'Donnel, P.V., Luznik, L., Jones, R.J., Vogelsang, G.B., Leffell, M.S., Phelps, M., Rhubart, P., Cowan, K., Piantadosi, S. and Fuchs, E.J. (2002) "Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using post-transplantation cyclophosphamide", Biol. Blood Marrow Transplant. 8, 377-386.